Research Scientist

Dr. Qiao-Hong Chen received her B.Sc. and M.S. (under the direction of Prof. Pei-Quan Yang) degrees from the school of Pharmacy at West China University of Medical Sciences in 1991 and 1998 respectively. In July 2001 upon completion of her Ph.D. program under the guidance of Prof. Feng-Peng Wang in the Department of Chemistry of Medicinal natural Products in the West China School of Pharmacy at Sichuan University, Dr. Chen was appointed as a lecturer in Sichuan University and was directly promoted to a full Professor in July 2003. Dr. Chen has received a few awards, including Award for Top 100 National Excellent Doctoral Dissertation in 2003 (the National Evaluation Institute of Degrees and Grade Education in China) and the First Class Prize of the Nature and Science of Chinese Advance Education (the Education Ministry of China, 2002). In addition, Dr. Chen was awarded the Alberta Heritage Foundation for Medical Research (AHFMR) Fast-track Post-Doctoral Fellowship (2003-2004, Canada), the Canada's Research-Based Pharmaceutical Companies Health Research Foundation (Rx&D-HRF) and Canadian Institutes of Health Research (CIHR) Post-Doctoral Fellowship in Pharmacy (2004-2006, Canada), and AHFMR Post-Doctoral Fellowship (incentive award, 2004-2006, Canada). The postdoctoral training from August 2003 to August 2006 under the guidance of Prof. Edward E. Knaus in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta involved the design and synthesis of selective cyclooxygenase-2 (COX-2) inhibitors and dual COX/LOX inhibitors. Dr. Chen joined Prof. Kingston's research group at Virginia Polytechnic Institute and State University (Virginia Tech) in the middle of August, 2006, and she is currently carrying out the research on Chemistry and Mechanism of Action of Tubulin-binding Anticancer Drugs.